CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Derivatives Options or other derivatives
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $22.52 ($22,524)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $21.59 ($70,178)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 28,367 shares at an average $24.18 ($685,868)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $25.04 ($25,039)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 4,250 shares at an average $22.23 ($94,474)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,250 shares at an average $24.89 ($130,688)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 14 of 40 · 798 filings